Rising Incidence of De Novo Anti-HLA DSA in African American Renal Transplant Recipients Over a Decade

被引：0
|
作者：
Dieplinger, G. [1 ]
Everly, M. [1 ]
Rebellato, L. [2 ]
Haisch, C. [2 ]
Briley, K. [2 ]
Bolin, P. [2 ]
Kendrick, W. [3 ]
Kendrick, S. [3 ]
Morgan, C. [2 ]
Hoermann, M. [1 ]
Maldonado, A. [4 ]
Harland, R. [2 ]
Terasaki, P. [1 ]
机构：
[1] Terasaki Fdn, Los Angeles, CA USA
[2] E Carolina Univ, Greenville, NC USA
[3] Eastern Nephrol Associates, Greenville, NC USA
[4] Vidant Med Ctr, Greenville, NC USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A237
引用
收藏
页码：467 / 467
页数：1
相关论文
共 50 条
  • [1] Rising Incidence of De Novo Anti-HLA DSA in African American Renal Transplant Recipients Over a Decade.
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Hoermann, M.
    Maldonado, A.
    Harland, R.
    Terasaki, P.
    TRANSPLANTATION, 2014, 98 : 467 - 467
  • [2] Relationship Between BK Viremia, De Novo Anti-HLA DSA, and Outcomes in Renal Transplant Recipients
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Hoermann, M.
    Maldonado, A.
    Harland, R.
    Terasaki, P.
    TRANSPLANTATION, 2014, 98 : 85 - 85
  • [3] Relationship Between BK Viremia, De Novo Anti-HLA DSA, and Outcomes in Renal Transplant Recipients.
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Hoermann, M.
    Maldonado, A.
    Harland, R.
    Terasaki, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 85 - 85
  • [4] Effect of SARS-CoV-2 Infection on Anti-HLA Antibodies and De Novo DSA Incidence in Lung Transplant Recipients
    Zajacova, A.
    Dvorackova, E.
    Vyskocilova, K.
    Casas-Mendez, L.
    Kotowski, T.
    Valentova-Bartakova, L.
    Fila, L.
    Lischke, R.
    Havlin, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S158 - S158
  • [5] De Novo Anti-HLA Sensitization in Pediatric Kidney Transplant Recipients
    Vila-Santandreu, A.
    Camacho, J.
    Vila-Cots, J.
    Ramos, M.
    Gondra, L.
    Martorell, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 672 - 672
  • [6] De Novo Anti-HLA Sensitization in Pediatric Kidney Transplant Recipients
    Vila-Santandreu, A.
    Camacho, J.
    Vila-Cots, J.
    Ramos, M.
    Gondra, L.
    Martorell, J.
    TRANSPLANTATION, 2014, 98 : 672 - 672
  • [7] Development of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients
    Chen, C. K.
    Manlhiot, C.
    Conway, J.
    Allain-Rooney, T.
    McCrindle, B. W.
    Tinckam, K.
    Dipchand, A. I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S193 - S193
  • [8] Role of rituximab for isolated de novo donor specific anti-HLA antibodies in renal transplant recipients
    Schafer, Antonia
    Ferrai-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [9] IMPACT OF EVEROLIMUS ON DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    TRANSPLANT INTERNATIONAL, 2013, 26 : 245 - 245
  • [10] When Is the Best Time to Screen for De Novo Donor Specific Anti-HLA Antibodies (DSA) in Low-Risk Renal Transplant Recipients?
    Everly, M.
    Rebellato-deVente, L. M.
    Haisch, C. E.
    Ozawa, M.
    Parker, K.
    Briley, K. P.
    Catrou, P. G.
    Bolin, P.
    Kendrick, W. T.
    Kendrick, S. A.
    Harland, R. C.
    Terasaki, P., I
    TRANSPLANTATION, 2012, 94 (10) : 1190 - 1190
12345